300463 邁克生物
按盤價 
14.200 +2.370 (+20.034%)
14.200 +2.370 (+20.034%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,607,884 | -17.44% | 2,548,757 | 2,895,770 | 3,608,412 | 3,980,647 | |
| 減：營業總成本 | 1,517,055 | -7.61% | 2,321,459 | 2,506,578 | 2,763,448 | 2,779,524 | |
| 其中:營業成本 | 708,494 | -15.02% | 1,144,092 | 1,295,318 | 1,651,771 | 1,673,940 | |
| 財務費用 | 12,282 | -15.49% | 16,434 | 23,310 | 18,289 | 57,869 | |
| 資產減值損失 | (12,177) | 73.33% | (100,824) | (58,037) | (23,973) | (17,634) | |
| 公允價值變動收益 | (11,380) | 31.28% | 2,148 | (7,077) | (9,104) | 0 | |
| 投資收益 | 598 | -82.36% | 2,879 | 8,592 | 12,145 | 395 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | 0 | 42 | 348 | 395 | |
| 營業利潤 | 61,984 | -80.54% | 169,965 | 331,145 | 817,395 | 1,214,066 | |
| 利潤總額 | 34,502 | -88.92% | 124,651 | 305,369 | 789,084 | 1,187,128 | |
| 減：所得稅費用 | (8,522) | -130.24% | 5,887 | 690 | 87,378 | 184,879 | |
| 淨利潤 | 43,024 | -84.80% | 118,764 | 304,679 | 701,705 | 1,002,248 | |
| 減：非控股權益 | 5,921 | 243.30% | (8,041) | (7,939) | (6,475) | 45,644 | |
| 股東淨利潤 | 37,103 | -86.81% | 126,805 | 312,619 | 708,180 | 956,604 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.061 | -86.93% | 0.209 | 0.514 | 1.173 | 1.731 | |
| 每股派息 (元) * | -- | -- | 0.104 | 0.154 | 0.349 | 0.471 | |
| 每股淨資產 (元) * | 10.462 | -1.95% | 10.399 | 10.425 | 10.275 | 7.725 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 26/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
